James is speculative, filled with assertions about James's "probable knowledge" and how his path to Spiritualism "most likely began" (p. 59). Knapp is on firmer ground in tracing the research that James began in earnest in the 1880s, when he engaged in investigations whose protocols emulated those applied in laboratories of experimental psychology.
Knapp offers vivid portraits of the founders of the British Society for Psychical Research, whom James met during a visit to England in 1882, and who formed a "dynamic brotherhood" welcoming James's participation (p. 101). They included philosopher Henry Sidgwick; Edmund Gurney and F. W. H. Myers, who had been Sidgwick's students at Cambridge; and Australian-born Richard Hodgson, who became one of the group's principal investigators of mediums. In 1884, urged by his British colleagues, James helped to found the American Society for Psychical Research, and devoted much time and effort serving on its committees to investigate hypnotism and mediumship.
Trance states, hypnosis, and automatic writing informed James's theories of subliminal consciousness and immortality. As Knapp acknowledges, James failed to conceive of a universal theory of the unconscious, while at the same time positing a "Mother Sea" of superhuman consciousness into which traces of selves floated in the cosmos after death. Knapp never resolves such thorny contradictions in James's work; but his notion of the tertium quid offers a sensible way to understand James's persistent quest to probe the ineffable, invisible realm of psychic phenomena. Between 1880 and 1920, physicians in the United States and Great Britain identified a small but concerning number of infants with severe mental and developmental retardation among Jewish immigrant families. Tay-Sachs disease (TSD), as this hereditary condition is known today, has no cure, but it can be effectively prevented through carrier screening or therapeutic abortion. Fortunately, beginning in the 1980s, aggressive carrier screening coordinated by Jewish communities and their medical partners dramatically reduced TSD's incidence in North America, Western Europe, and Israel. In 2003-4, for instance, only ten such babies were born in the United States, none Jewish. As the latter example suggests, TSD is not an exclusively Jewish disease. Yet, TSD carrier screening among Jewish communities is often hailed today as an exemplar of successful grassroots public health advocacy within an ethnic group-a kind of self-empowerment with
